Circulating endothelial cells as biomarkers in clinical oncology

Microvascular Research

Volumn 79, Issue 3, 2010, Pages 224-228

  Mancuso, Patrizia ^a   Bertolini, Francesco ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Angiogenesis; Endothelial cells; Endothelial progenitors

Indexed keywords

BEVACIZUMAB; CD133 ANTIGEN; CD34 ANTIGEN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; BLOOD VESSEL INJURY; BREAST CANCER; CANCER GROWTH; CELL COUNT; CELL VIABILITY; CIRCULATING ENDOTHELIAL CELL; CIRCULATING ENDOTHELIAL PROGENITOR CELL; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; HUMAN; METASTASIS; METASTASIS POTENTIAL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; STEM CELL; STEM CELL MOBILIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; CELL PROLIFERATION; CELL SURVIVAL; ENDOTHELIAL CELLS; HUMANS; NEOPLASM, RESIDUAL; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PHENOTYPE; PREDICTIVE VALUE OF TESTS; STEM CELLS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 77952093536     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2010.02.007     Document Type: Review

References (55)

1. Adighibe O., Micklem K., Campo L., Ferguson M., Harris A., Pozos R., Gatter K., Pezzella F. Is nonangiogenesis a novel pathway for cancer progression? A study using 3-dimensional tumour reconstructions. Br. J. Cancer 2006, 24,94(8):1176-1179.
2. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., Witzenbichler B., Schatteman G., Isner J.M. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
3. Bergers G., Hanahan D. Models of resistance to anti-angiogenic therapy. Nat. Rev. Cancer 2008, 8(8):592-603.
4. Bertolini F., Shaked Y., Mancuso P., Kerbel R.S. The multifaceted circulating endothelial cell in cancer: towards marker and target identification. Nat. Rev. Cancer 2006, 6:835-845.
5. Blann A.D., Woywodt A., Bertolini F., Bull T.M., Buyon J.P., Clancy R.M., Haubitz M., Hebbel R.P., Lip G.Y., Mancuso P., Sampol J., Solovey A., Dignat-George F. Circulating endothelial cells. Biomarker of vascular disease. Thromb. Haemost. 2005, 93:228-235.
6. Calleri A., Bono A., Bagnardi V., Quarna J., Mancuso P., Rabascio C., Dellapasqua S., Campagnoli E., Shaked Y., Goldhirsch A., Colleoni M., Bertolini F. Predictive potential of angiogenic growth factors and circulating endothelial cells in breast cancer patients receiving metronomic chemotherapy plus bevacizumab. Clin. Cancer Res. 2009, 15:7652-7657.
7. Case J., Mead L.E., Bessler W.K., Prater D., White H.A., Saadatzadeh M.R., Bhavsar J.R., Yoder M.C., Haneline L.S., Ingram D.A. Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp. Hematol. 2007, 35:1109-1118.
8. Ciarrocchi A., Jankovic V., Shaked Y., Nolan D.J., Mittal V., Kerbel R.S., Nimer S.D., Benezra R. Id1 restrains p21 expression to control endothelial progenitor cell formation. PLoS ONE 2007, 2:1338.
9. Della Porta M.G., Malcovati L., Rigolin G.M., Rosti V., Bonetti E., Travaglino E., Boveri E., Galli A., Boggi S., Ciccone M., Pramparo T., Mazzini G., Invernizzi R., Lazzarino M., Cazzola M. Immunophenotypic, cytogenetic and functional characterization of circulating endothelial cells in myelodysplastic syndromes. Leukemia 2008, 22:530-537.
10. Dellapasqua S., Bertolini F., Bagnardi V., Campagnoli E., Scarano E., Torrisi R., Shaked Y., Mancuso P., Goldhirsch A., Rocca A., Pietri E., Colleoni M. Metronomic cyclophosphamide and capecitabine combined with bevacizumab in advanced breast cancer. J. Clin. Oncol. 2008, 26:4899-4905.
11. Dome B., Timar J., Dobos J., Meszaros L., Raso E., Paku S., Kenessey I., Ostoros G., Magyar M., Ladanyi A., Bogos K., Tovari J. Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer. Cancer Res. 2006, 15;66(14):7341-7347.
12. Farace F., Massard C., Borghi E., Bidart J.M., Soria J.C. Vascular disrupting therapy-induced mobilization of circulating endothelial progenitor cells. Ann. Oncol. 2007, 18:1421-1422.
13. Folkman J., Kalluri R. Cancer without disease. Nature 2004, 427:787.
14. Gao D., Mittal V. The role of bone-marrow-derived cells in tumor growth, metastasis initiation and progression. Trends Mol. Med. 2009, 15(8):333-343.
15. Gao D., Nolan D.J., Mellick A.S., Bambino K., McDonnell K., Mittal V. Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science 2008, 319:195-1998.
16. Goon P.K., Lip G.Y., Stonelake P.S., Blann A.D. Circulating endothelial cells and circulating progenitor cells in breast cancer: relationship to endothelial damage/dysfunction/apoptosis, clinicopathologic factors, and the Nottingham Prognostic Index. Neoplasia 2009, 11(8):771-779.
17. Gora-Tybor J., Jamroziak K., Szmigielska-Kaplon A., Krawczynska A., Lech-Maranda E., Wierzbowska A., Jesionek-Kupnicka D., Blonski J.Z., Robak T. Evaluation of circulating endothelial cells as noninvasive marker of angiogenesis in patients with chronic lymphocytic leukemia. Leuk. Lymphoma 2009, 50(1):62-67.
18. Greenfield J.P., Jin D.K., Young L.M., Christos P.J., Abrey L., Rafii S., Gutin P.H. Surrogate markers predict angiogenic potential and survival in patients with glioblastoma multiforme. Neurosurgery 2009, 64(5):819-826. (discussion 826-827).
19. Gunsilius E. Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells. Adv. Exp. Med. Biol. 2003, 522:17-24.
20. Hladovec J., Rossamn P. Circulating endothelial cells isolated together with platelets and the experimental modification of their counts in rats. Thromb Res. 1973, 3:665-674.
21. Igreja C., Courinha M., Cachaço A.S., Pereira T., Cabeçadas J., da Silva M.G., Dias S. Characterization and clinical relevance of circulating and biopsy-derived endothelial progenitor cells in lymphoma patients. Haematologica 2007, 92(4):469-477.
22. Jain R.K., Duda D.G., Willett C.G., Sahani D.V., Zhu A.X., Loeffler J.S., Batchelor T.T., Sorensen A.G. Biomarkers of response and resistance to antiangiogenic therapy. Nat. Rev. Clin. Oncol. 2009, 6(6):327-338.
23. Kaplan R.N., Riba R.D., Zacharoulis S., Bramley A.H., Vincent L., Costa C., MacDonald D.D., Jin D.K., Shido K., Kerns S.A., Zhu Z., Hicklin D., Wu Y., Port J.L., Altorki N., Port E.R., Ruggero D., Shmelkov S.V., Jensen K.K., Rafii S., Lyden D. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005, 8:820-827.
24. Kerbel R.S. Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agents. Bioessays 1991, 13:31-36.
25. Kerbel R.S., Folkman J. Clinical translation of angiogenesis inhibitors. Nat. Rev. Cancer 2002, 2:727-739.
26. Kilarski W.W., Samolov B., Petersson L., Kvanta A., Gerwins P. Biomechanical regulation of blood vessel growth during tissue vascularization. Nat. Med. 2009, 15(6):657-664.
27. Lee S., Chen T.T., Barber C.L., Jordan M.C., Murdock J., Desai S., Ferrara N., Nagy A., Roos K.P., Iruela-Arispe M.L. Autocrine VEGF signaling is required for vascular homeostasis. Cell 2007, 130:691-703.
28. Lyden D., Hattori K., Dias S., Costa C., Blaikie P., Butros L., Chadburn A., Heissig B., Marks W., Witte L., Wu Y., Hicklin D., Zhu Z., Hackett N.R., Crystal R.G., Moore M.A., Hajjar K.A., Manova K., Benezra R., Rafii S. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med. 2001, 7:1194-1201.
29. Madlambayan G.J., Butler J.M., Hosaka K., Jorgensen M., Fu D., Guthrie S.M., Shenoy A.K., Brank A., Russell K.J., Otero J., Siemann D.W., Scott E.W., Cogle C.R. Bone marrow stem and progenitor cell contribution to neovasculogenesis is dependent on model system with SDF-1 as a permissive trigger. Blood 2009, 5, 114(19):4310-4319.
30. Mancuso P., Burlini A., Pruneri G., Goldhirsch A., Martinelli G., Bertolini F. Resting and activated endothelial cells are increased in the peripheral blood of cancer patients. Blood 2001, 97:3658-3661.
31. Mancuso P., Colleoni M., Calleri A., Orlando L., Maisonneuve P., Pruneri G., Agliano A., Goldhirsch A., Shaked Y., Kerbel R.S., Bertolini F. Circulating endothelial cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy. Blood 2006, 108:452-459.
32. Mancuso P., Antoniotti P., Quarna J., Calleri A., Rabascio C., Tacchetti C., Braidotti P., Wu H.K., Zurita A.J., Saronni L., Cheng J.B., Shalinsky D.R., Heymach J.V., Bertolini F. Validation of a standardized method for enumerating circulating endothelial cells and progenitors: flow cytometry and molecular and ultrastructural analyses. Clin. Cancer Res. 2009, 1;15(1):267-273.
33. Mizrak D., Brittan M., Alison M.R. CD133: molecule of the moment. J. Pathol. 2008, 214:3-9.
34. Moldovan N.I., Moldovan L., Simionescu N. Binding of vascular anticoagulant alpha (annexin V) to the aortic intima of the hypercholesterolemic rabbit. An autoradiographic study. Blood Coagul. Fibrinolysis 1994, 5:921-928.
35. Monestiroli S., Mancuso P., Burlini A., Pruneri G., Dell'Agnola C., Gobbi A., Martinelli G., Bertolini F. Kinetics and viability of circulating endothelial cells as surrogate angiogenesis marker in an animal model of human lymphoma. Cancer Res. 2001, 61:4341-4344.
36. Naik R.P., Jin D., Chuang E., Gold E.G., Tousimis E.A., Moore A.L., Christos P.J., de Dalmas T., Donovan D., Rafii S., Vahdat L.T. Circulating endothelial progenitor cells correlate to stage in patients with invasive breast cancer. Breast Cancer Res. Treat. 2008, 107(1):133-138.
37. Nolan D.J., Ciarrocchi A., Mellick A.S., Jaggi J.S., Bambino K., Gupta S., Heikamp E., McDevitt M.R., Scheinberg D.A., Benezra R., Mittal V. Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization. Genes Dev. 2007, 21:1546-1558.
38. Norden-Zfoni A., Desai J., Manola J., Beaudry P., Force J., Maki R., Folkman J., Bello C., Baum C., DePrimo S.E., Shalinsky D.R., Demetri G.D., Heymach J.V. Blood-based biomarkers of SU11248 activity and clinical outcome in patients with metastatic imatinib-resistant gastrointestinal stromal tumor. Clin. Cancer Res. 2007, 13:2643-2650.
39. Peichev M., Naiyer A.J., Pereira D., Zhu Z., Lane W.J., Williams M., Oz M.C., Hicklin D.J., Witte L., Moore M.A., Rafii S. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000, 1;95(3):952-958.
40. Peters B.A., Diaz L.A., Polyak K., Meszler L., Romans K., Guinan E.C., Antin J.H., Myerson D., Hamilton S.R., Vogelstein B., Kinzler K.W., Lengauer C. Contribution of bone marrow-derived endothelial cells to human tumor vasculature. Nat. Med. 2005, 11(3):261-262.
41. Rabascio C., Muratori E., Mancuso P., Calleri A., Raia V., Foutz T., Cinieri S., Veronesi G., Pruneri G., Lampertico P., Iavarone M., Martinelli G., Goldhirsch A., Bertolini F. Assessing tumor angiogenesis: increased circulating VE-cadherin RNA in patients with cancer indicates viability of circulating endothelial cells. Cancer Res. 2004, 15:4373-4377.
42. Rafii S., Lyden D., Benezra R., Hattori K., Heissig B. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?. Nat. Rev. Cancer 2002, 2:826-835.
43. Rosenzweig A. Circulating endothelial progenitors - cells as biomarkers. N. Engl. J. Med. 2005, 353:1055-1057.
44. Ruzinova M.B., Schoer R.A., Gerald W., Egan J.E., Pandolfi P.P., Rafii S., Manova K., Mittal V., Benezra R. Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors. Cancer Cell 2003, 4:277-289.
45. Schneider M., Tjwa M., Carmeliet P. A surrogate marker to monitor angiogenesis at last. Cancer Cell 2005, 7:3-4.
46. Seaman S., Stevens J., Yang M.Y., Logsdon D., Graff-Cherry C., St.Croix B. Genes that distinguish physiological and pathological angiogenesis. Cancer Cell 2007, 11:539-554.
47. Seande M., Butler J., Lyden D., Rafii S. A catalytic role for proangiogenic marrow-derived cells in tumor neovascularization. Cancer Cell 2008, 13:181-183.
48. Shaked Y., Bertolini F., Man S., Rogers M.S., Cervi D., Foutz T., Rawn K., Voskas D., Dumont D.J., Ben-David Y., Lawler J., Henkin J., Huber J., Hicklin D.J., D'Amato R.J., Kerbel R.S. Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; implications for cellular surrogate marker analysis of antiangiogenesis. Cancer Cell 2005, 7:101-111.
49. Shaked Y., Emmenegge U., Man S., Cervi D., Bertolini F., Ben-David Y., Kerbel R.S. Optimal biologic dose of metronomic chemotherapy regimens is associated with maximum antiangiogenic activity. Blood 2005, 106:3058-3061.
50. Shaked Y., Ciarrocchi A., Franco M., Lee C.R., Man S., Cheung A.M., Hicklin D.J., Chaplin D., Foster F.S., Benezra R., Kerbel R.S. Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors. Science 2006, 22:1785-1787.
51. Shaked Y., Henke E., Roodhart J.M., Mancuso P., Langenberg M.H., Colleoni M., Daenen L.G., Man S., Xu P., Emmenegger U., Tang T., Zhu Z., Witte L., Strieter R.M., Bertolini F., Voest E.E., Benezra R., Kerbel R.S. Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents. Cancer Cell 2008, 14:263-273.
52. Shen R., Ye Y., Chen L., Yan Q., Barsky S.H., Gao J.X. Precancerous stem cells can serve as tumor vasculogenic progenitors. PLoS ONE 2008, 3:e-1652.
53. Shi Q., Rafii S., Wu M.H., Wijelath E.S., Yu C., Ishida A., Fujita Y., Kothari S., Mohle R., Sauvage L.R., Moore M.A., Storb R.F., Hammond W.P. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998, 92:362-367.
54. Wierzbowska A., Robak T., Krawczyńska A., Pluta A., Wrzesień-Kuś A., Cebula B., Robak E., Smolewski P. Kinetics and apoptotic profile of circulating endothelial cells as prognostic factors for induction treatment failure in newly diagnosed acute myeloid leukemia patients. Ann. Hematol. 2008, 87(2):97-106.
55. Yoder M.C., Mead L.E., Prater D., Krier T.R., Mroueh K.N., Li F., Krasich R., Temm C.J., Prchal J.T., Ingram D.A. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007, 109:1801-1809.